Table 1 Baseline clinical and biochemical data of cases and controls

Age, years

52.0 ± 9.0

53.2 ± 7.1

NS

Sex (male), n (%)

61 (36%)

46 (36%)

NS

Weight, kg

64.7 ± 9.8

83.5 ± 14.1

0.00001

Essential hypertension, n (%)

0

69 (54.3%)

–

SBP, mm Hg

122.0 ± 10.6

148.6 ± 27.0

0.00001

DBP, mm Hg

79.3 ± 9.3

91.7 ± 14.5

0.00001

Type 2 diabetes, n (%)

0

69 (54%)

–

Blood glucose, mmol/l

5.20 [5.01;5.48]

7.33 [5.49;8.48]

0.001

MS, n (%)

0

114 (90%)

–

Obesity, n (%)

0

95 (75%)

–

BMI, kg/m²

24.1 ± 2.7

31.5 ± 4.1

0.00001

WC (cm)

83.2 ± 8.6

104.1 ± 9.2

0.00001

HC (cm)

95.6 ± 7.8

109.5 ± 8.6

0.00001

TC, mmol/l

5.0 ± 0.9

5.1 ± 1.0

NS

HDLC, mmol/l

3.2 ± 0.8

1.0 ± 0.3

0.00001

LDLC, mmol/l

1.3 ± 0.4

3.2 ± 0.9

0.00001

TG, mmol/l

1.2 ± 0.7

2.1 ± 1.5

0.00001

НОМА-IR

0

46 (36%)

–

Insulin, μIU/ml

5.08 [3.35;6.65]

12.7 [7.52;15.90]

0.001